Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Dividend history for Third Harmonic Bio, Inc. (THRD)
Third Harmonic Bio, Inc. made a total of 21 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $2.26
Dividend payments for Third Harmonic Bio, Inc. (THRD) from 2009 to 2014
Annual dividend payments
| Date | Dividend | Adj Dividend |
|---|---|---|
| August 06, 14 | $0.12 | $0.12 |
| May 06, 14 | $0.12 | $0.12 |
| February 05, 14 | $0.12 | $0.12 |
| November 06, 13 | $0.10 | $0.10 |
| August 06, 13 | $0.10 | $0.10 |
| May 06, 13 | $0.05 | $0.05 |
| February 06, 13 | $0.05 | $0.05 |
| November 06, 12 | $0.05 | $0.05 |
| August 06, 12 | $0.05 | $0.05 |
| May 04, 12 | $0.05 | $0.05 |
| February 06, 12 | $0.05 | $0.05 |
| November 04, 11 | $0.05 | $0.05 |
| August 04, 11 | $0.05 | $0.05 |
| May 05, 11 | $0.05 | $0.05 |
| February 04, 11 | $0.05 | $0.05 |
| November 04, 10 | $0.20 | $0.20 |
| August 05, 10 | $0.20 | $0.20 |
| May 06, 10 | $0.20 | $0.20 |
| February 05, 10 | $0.20 | $0.20 |
| November 05, 09 | $0.20 | $0.20 |
| August 05, 09 | $0.20 | $0.20 |